Investigating how a specific protein affects brain aging and Alzheimer's disease
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease
This study is looking at a protein called IL-33 in the aging brain to see how it affects the brain's ability to get rid of harmful substances linked to Alzheimer's disease, with the hope of finding new ways to help people with Alzheimer's and similar conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11092778 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of IL-33, a protein produced by oligodendrocytes, in the aging brain and its implications for Alzheimer's disease. By studying how IL-33 levels change with age and how they influence the brain's ability to clear harmful substances like amyloid plaques, the research aims to uncover potential therapeutic strategies. The approach involves analyzing brain cells and their responses to age-related changes, which could lead to new insights into cognitive decline and neurodegenerative diseases. Patients may benefit from findings that could inform future treatments for Alzheimer's and other age-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those at risk for or diagnosed with Alzheimer's disease.
Not a fit: Patients who are younger than one year old or those without any cognitive decline may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve cognitive function and slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of neuroinflammation and specific proteins in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kang, Shin H — Temple Univ of the Commonwealth
- Study coordinator: Kang, Shin H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.